BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
2226 results:

  • 1. cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
    Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
    Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma.
    Sun Y; Ma Q; Chen Y; Liao D; Kong F
    Clin Respir J; 2024 May; 18(5):e13755. PubMed ID: 38757752
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Patterns of distant metastasis and survival outcomes in
    Liu K; Huang AL; Chen XQ; Wu SG
    Front Endocrinol (Lausanne); 2024; 15():1385756. PubMed ID: 38752173
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Effect of peripheral blood inflammatory indicators on the efficacy of immunotherapy in patients with advanced non-small cell lung cancer and chronic obstructive pulmonary disease].
    Bi ZK; Xu Y; Guo L; Zhang WJ; You YT; Li JW; Zhao CL; Shan YF; Xia TT; Li YF; Xu Z; Fan Y; Bai L
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1601-1609. PubMed ID: 38742347
    [No Abstract]    [Full Text] [Related]  

  • 5. Prognostic implications of STK11 with different mutation status and its relationship with tumor-infiltrating immune cells in non-small cell lung cancer.
    Zheng J; Deng Y; Huang B; Chen X
    Front Immunol; 2024; 15():1387896. PubMed ID: 38736875
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Transcript and protein signatures derived from shared molecular interactions across cancers are associated with mortality.
    Zhao Y; Li X; Loscalzo J; Smelik M; Sysoev O; Wang Y; Mahmud AKMF; Mansour Aly D; Benson M
    J Transl Med; 2024 May; 22(1):444. PubMed ID: 38734658
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Risk and prognosis of secondary lung cancer after radiation therapy for thoracic malignancies.
    Chen K; Liu C; Li X; Chen T; Liu S; Xiong F; Zhang Z
    Clin Respir J; 2024 May; 18(5):e13760. PubMed ID: 38725324
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Novel genome-wide DNA methylation profiling reveals distinct epigenetic landscape, prognostic model and cellular composition of early-stage lung adenocarcinoma.
    Gan J; Huang M; Wang W; Fu G; Hu M; Zhong H; Ye X; Cao Q
    J Transl Med; 2024 May; 22(1):428. PubMed ID: 38711158
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric cancer.
    Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
    J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Treatment strategies for stage IA non-small cell lung cancer: A SEER-based population study.
    Wu B; Zhang X; Feng N; Hu Z; Wu J; Zhou W; Wei Y; Zhang W; Wang K
    PLoS One; 2024; 19(4):e0298470. PubMed ID: 38683794
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Evaluation and Management of lung Metastases in Patients with Giant Cell Tumors of Bone in the Denosumab Era.
    Trovarelli G; Rizzo A; Cerchiaro M; Pala E; Angelini A; Ruggieri P
    Curr Oncol; 2024 Apr; 31(4):2158-2171. PubMed ID: 38668063
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials.
    Zhang W; Liang Z; Zhao Y; Li Y; Chen T; Li W; Chen Y; Wu P; Zhang H; Fang C; Li L
    Front Immunol; 2024; 15():1359302. PubMed ID: 38646542
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer: a comprehensive study based on meta-analyses and bioinformatics analyses.
    Xu K; Lu W; Yu A; Wu H; He J
    BMC Cancer; 2024 Apr; 24(1):491. PubMed ID: 38632512
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Uncertainty among patients with advanced-stage lung cancer.
    Wongkalasin K; Matchim Y; Kanhasing R; Pimvichai S
    Int J Palliat Nurs; 2024 Apr; 30(4):160-169. PubMed ID: 38630643
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma.
    Midorikawa K; Miyahara S; Nishino N; Ueda Y; Waseda R; Shiraishi T; Sato T
    J Cardiothorac Surg; 2024 Apr; 19(1):225. PubMed ID: 38627811
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Impact of immune checkpoint inhibitors (ICIs) therapy on interferon-γ release assay (IGRA) and diagnostic value in non-small cell lung cancer (NSCLC) patients.
    Xu Y; Zhang Q; Chen Z; Yang S; Chen H; Xiao X; Jiang H
    BMC Pulm Med; 2024 Apr; 24(1):174. PubMed ID: 38609918
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Multicentre retrospective analysis on pulmonary metastasectomy: an European perspective.
    Prisciandaro E; Bertolaccini L; Fieuws S; Cara A; Spaggiari L; Huang L; Petersen RH; Ambrogi MC; Sicolo E; Barbarossa A; De Leyn P; Sporici D; Balsamo L; Donlagic A; Gonzalez M; Fuentes-Gago MG; Forcada-Barreda C; Congedo MT; Margaritora S; Belaroussi Y; Thumerel M; Tricard J; Felix P; Lebeda N; Opitz I; De Palma A; Marulli G; Braggio C; Thomas PA; Mbadinga F; Baste JM; Sayan B; Yildizeli B; Van Raemdonck DE; Weder W; Ceulemans LJ
    Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38579246
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A population study comparing tracheal and lung adenoid cystic carcinoma.
    Gu Y; Lai S; Wang Y; Yang J; Zhou P; Chen T
    Cancer Med; 2024 Apr; 13(7):e7158. PubMed ID: 38572933
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
    Li J; Ma X; Xu F; Yan Y; Chen W
    Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Martin-Giacalone BA; Li H; Scheurer ME; Casey DL; Dugan-Perez S; Marquez-Do DA; Muzny D; Gibbs RA; Barkauskas DA; Hall D; Stewart DR; Schiffman JD; McEvoy MT; Khan J; Malkin D; Linardic CM; Crompton BD; Shern JF; Skapek SX; Venkatramani R; Hawkins DS; Sabo A; Plon SE; Lupo PJ
    JAMA Netw Open; 2024 Mar; 7(3):e244170. PubMed ID: 38546643
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 112.